| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-05 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.24 | 3e-05 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.0001 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.091 | 0.002 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.16 | 0.003 |